Abstract
It has been demonstrated by clinical and animal studies that stress stimulation plays a pivotal role in the tumor development and progression. Adrenergic system activation mediates most of the effects resulting from stress stimulation. Various cigarette components have been indicated for inducing the secretion of stress hormones such as noradrenaline and adrenaline which activate the adrenoceptors expressed on tumor cells and initiate different biological effects. Gastrointestinal (GI) cancers, a common malignancy in the body are also influenced by stress stimulation to a great extent. Combined stress stimulation with cigarette smoking can further accelerate tumor progression, and even develop chemoresistance in cancer cells. Therefore the involvement of adrenoceptors in these biological processes and habitual behaviours are becoming interesting therapeutic targets. Indeed various adrenoceptor blockers are implicated as promising therapeutic agents to prevent and treat relevant cancers including those in the GI tract. In this review, we sum up the possible relationship between the adrenergic system and GI cancers and provide a mechanistic understanding on this relationship. Meanwhile, we also further discuss the roles of cigarette smoke and its active ingredient nicotine which is highly associated with the adrenergic system in the development of GI cancers.
Keywords: Adrenergic system, adrenoceptors, β-blocker, GI cancers, nicotine, stress
Current Cancer Therapy Reviews
Title:The Adrenergic System in Gastrointestinal Cancers
Volume: 8 Issue: 2
Author(s): Zhi Jie Li and Chi Hin Cho
Affiliation:
Keywords: Adrenergic system, adrenoceptors, β-blocker, GI cancers, nicotine, stress
Abstract: It has been demonstrated by clinical and animal studies that stress stimulation plays a pivotal role in the tumor development and progression. Adrenergic system activation mediates most of the effects resulting from stress stimulation. Various cigarette components have been indicated for inducing the secretion of stress hormones such as noradrenaline and adrenaline which activate the adrenoceptors expressed on tumor cells and initiate different biological effects. Gastrointestinal (GI) cancers, a common malignancy in the body are also influenced by stress stimulation to a great extent. Combined stress stimulation with cigarette smoking can further accelerate tumor progression, and even develop chemoresistance in cancer cells. Therefore the involvement of adrenoceptors in these biological processes and habitual behaviours are becoming interesting therapeutic targets. Indeed various adrenoceptor blockers are implicated as promising therapeutic agents to prevent and treat relevant cancers including those in the GI tract. In this review, we sum up the possible relationship between the adrenergic system and GI cancers and provide a mechanistic understanding on this relationship. Meanwhile, we also further discuss the roles of cigarette smoke and its active ingredient nicotine which is highly associated with the adrenergic system in the development of GI cancers.
Export Options
About this article
Cite this article as:
Jie Li Zhi and Hin Cho Chi, The Adrenergic System in Gastrointestinal Cancers, Current Cancer Therapy Reviews 2012; 8 (2) . https://dx.doi.org/10.2174/157339412800675379
DOI https://dx.doi.org/10.2174/157339412800675379 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics
The thematic issue "Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics" aims to explore cutting-edge developments and innovative strategies in the field of lipid nanoparticle (LNP) technology, particularly focusing on its application in mRNA delivery. This topic has gained unprecedented attention and urgency in the wake of the COVID-19 ...read more
Current Progress in Protein Degradation and Cancer Therapy
Targeted Protein Degradation is gaining momentum in cancer therapy; it facilitates targeting undruggable proteins, overcomes cancer resistance, and avoids undesirable side effects. Thus small molecule degraders have emerged as novel therapeutic strategies. Targeted protein degradation (TPD), the process of eliminating a protein of interest holds a great promise for the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Main Anti-tumor Angiogenesis Agents Isolated From Chinese Herbal Medicines
Mini-Reviews in Medicinal Chemistry Antitumor Effects of Celastrol and Semi-Synthetic Derivatives
Mini-Reviews in Organic Chemistry Signal Transduction Pathways and Transcription Factors as Therapeutic Targets in Inflammatory Disease: Towards Innovative Antirheumatic Therapy
Current Pharmaceutical Design Novel Molecular-Targeted Therapeutics for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Soy Protein Remnants Digested by Gastro-duodenal Proteases can Alter Microbial Interactions and Intestinal Cholesterol Absorption
Current Proteomics Recent Patents on Biomedical Devices and Nanomaterials for Hyperthermal Therapy of Cancer
Recent Patents on Nanomedicine Novel [1,2,4] Triazol [4,3-a] Pyridine Derivatives as Potential Selective c-Met Inhibitors with Improved Pharmacokinetic Properties
Anti-Cancer Agents in Medicinal Chemistry PI3K Inhibitors for Cancer Therapy: What has been Achieved So Far?
Current Medicinal Chemistry Novel Anticancer Agents and Targets: Recent Advances and Future Perspectives
Mini-Reviews in Medicinal Chemistry The Radionuclide Molecular Imaging and Therapy of Neuroendocrine Tumors
Current Cancer Drug Targets Tumor Necrosis Factor Alpha in Ulcerative Colitis and Diverticular Disease Associated Colitis
Endocrine, Metabolic & Immune Disorders - Drug Targets Pioglitazone and Cancer: Angel or Demon?
Current Pharmaceutical Design Low Dose of Anisodine Hydrobromide Induced Neuroprotective Effects in Chronic Cerebral Hypoperfusion Rats
CNS & Neurological Disorders - Drug Targets Targeting Soluble Epoxide Hydrolase for Inflammation and Pain - An Overview of Pharmacology and the Inhibitors
Inflammation & Allergy - Drug Targets (Discontinued) Ion Exchange Resins Transforming Drug Delivery Systems
Current Drug Delivery Evaluation and Exploitation of Bioactive Compounds of Walnut, Juglans regia
Current Pharmaceutical Design Macrolides as Immunomodulatory Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Editorial [Hot topic: Models and Evolution of Inflammatory Activities (Executive Editor: Giuseppe Scapigliati)]
Current Pharmaceutical Design Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer
Mini-Reviews in Medicinal Chemistry Development of Pin1 Inhibitors and their Potential as Therapeutic Agents
Current Medicinal Chemistry